Cannabis Market in Wisconsin

Wisconsin has one of the most limited cannabis frameworks in the Midwest. Lydia's Law, passed in 2014, allows patients with seizure disorders to use CBD oil with a physician's certification. However, the law does not establish any production, distribution, or dispensary infrastructure within the state. For practical purposes, the only legal cannabis-related products available in Wisconsin are hemp-derived CBD products meeting the federal 0.3% THC threshold.

Governor Tony Evers has been a vocal advocate for cannabis reform, repeatedly including both medical and recreational legalization in his executive budget proposals. However, the Republican-controlled state legislature has consistently rejected these proposals, and standalone cannabis bills have failed to advance through the legislative process. Despite polling showing strong bipartisan support for both medical and recreational legalization among Wisconsin voters, the political dynamics in Madison have prevented any meaningful progress.

Wisconsin's position is particularly notable given its proximity to legal markets. Illinois, which borders Wisconsin to the south, has a mature recreational market, and Michigan to the east also offers recreational sales. These neighboring markets attract significant cannabis spending from Wisconsin residents, representing lost tax revenue and economic activity. The estimated $15 million in cannabis-related retail activity comes entirely from hemp-derived CBD products. Wisconsin's population of approximately 5.9 million makes it one of the larger untapped cannabis markets in the country, and legalization would represent a significant market opportunity for both local operators and MSOs.

The Wisconsin cannabis market is regulated by the N/A — No cannabis licensing program, which oversees licensing, compliance, and enforcement for all cannabis businesses operating within the state. The regulatory body is responsible for issuing and renewing licenses, conducting inspections, enforcing packaging and labeling requirements, managing the seed-to-sale tracking system, and handling complaints and disciplinary actions.

The current tax structure for cannabis in Wisconsin is: N/A — No cannabis program; standard 5% sales tax applies to CBD products. Tax policy plays a critical role in determining the competitiveness of the legal cannabis market relative to the illicit market. States with excessively high tax rates often see consumers shift to unlicensed sources, while states with moderate rates tend to achieve higher legal market capture. Operators in Wisconsin must also comply with comprehensive regulatory requirements including testing, labeling, advertising restrictions, and security protocols.

Investors considering exposure to the Wisconsin cannabis market should evaluate several factors. The state's medical legal status, estimated market size of $15M, and limited MSO presence all influence the investment landscape. Market maturity, competitive dynamics, and regulatory stability are important considerations when evaluating companies with Wisconsin operations.

Cannabis stocks carry significant risks including federal illegality, regulatory uncertainty, limited access to banking services, and high tax burdens under IRC Section 280E. State-level factors such as license availability, tax rates, and enforcement against the illicit market can materially impact the profitability of licensed operators. Investors should consider a company's overall state portfolio diversification rather than relying on exposure to any single state market. Past performance does not guarantee future results, and cannabis investments may not be suitable for all investors.